News
Dias Carneiro advises IDB Invest on the financing for the implementation and operation of a cancer center by Albert Einstein Hospital
Dias Carneiro Advogados acted as Brazilian counsel to Inter-American Investment Corporation in the USD 100,000,000 financing to Sociedade Beneficente Israelita Hospital Brasileira Albert Einstein (“Einstein”), for the implementation and operation of a state-of-the-art oncology hospital in the city and State of São Paulo, which includes: 160 automated beds and 10 surgery rooms (1 hybrid room and 2 robotic surgery rooms), 5 image-guided intervention rooms, diagnostic medicine, medical offices and special areas for chemo and radiotherapy.
With the development of this cancer center, Einstein envisions to be one of the global leaders in oncology and hematology with: (i) a world-class academic research center focused on evidence-based multidisciplinary care and innovation; (ii) a center of excellence in precision medicine with a focus on genetics, genomics, immunotherapy, cell therapy and advanced therapeutics; (iii) predictive analysis and Big Data for prevention, accurate diagnosis and optimized results; (iv) industry partnerships in research, therapies and biotechnology driving innovation; and (v) culture of education and continuous learning.
IDB Invest’s in house counsel: Patricia Alves de Toledo
IDB Invest’s local counsel: Dias Carneiro – Partners: Thiago Vallandro Flores and Gustavo Junqueira; and Associates: Pedro Malvezzi de Araújo and Luiza De Munno
IDB Invest’s international counsel: Hunton Andrews Kurth LLP – Partner: Vera Rechsteiner; and Associate: Jessica Rivero
Einstein’s in house counsel: Rogéria Leoni Cruz and Catarine do Prado Castro
Einstein’s local counsel: Veirano Advogados – Partner: Renata Fialho de Oliveira; and Associates: Reginaldo Sorrenti Marcello Neto, Elisa Rezende and Katrine Costa de Azevedo
Einstein’s international counsel: Paul Hastings LLP – Partners: Thomas R. Sines and Jonathan E. Kellner; and Associate: Bruna Rey
